Jay E. Gold
Impact in
- Oncology top 10%
- Viral-associated cancers and disorders
- CAR-T cell therapy research
- Polyomavirus and related diseases
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in ⓘ
- Oncology 14
- CAR-T cell therapy research 7
- Viral-associated cancers and disorders 6
- Cancer Immunotherapy and Biomarkers 2
-
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 4
- Co-authors
- Ralph Zalusky (8 shared papers)Amjad Khan (2 shared papers)Michael E. Osband (8 shared papers)H. J. Ree (2 shared papers)S. Malamud (4 shared papers)Antonio Castella (3 shared papers)James A. Strauchen (1 shared paper)V. S. Ghali (3 shared papers)
- Journals
- Cancer (6 papers)American Journal of Hematology (4 papers)Journal of Surgical Oncology (2 papers)European Journal of Cancer (1 paper)Cancer Treatment Reviews (1 paper)
- Partner nations
- United States
In The Last Decade
Jay E. Gold
21 papers receiving 395 citations
Peers
Comparison fields: 5 of 46
- Oncology 235
- Pathology and Forensic Medicine 151
- Genetics 60
- Hematology 50
- Neurology 67
Countries citing papers authored by Jay E. Gold
This map shows the geographic impact of Jay E. Gold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay E. Gold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay E. Gold more than expected).
Fields of papers citing papers by Jay E. Gold
This network shows the impact of papers produced by Jay E. Gold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay E. Gold. The network helps show where Jay E. Gold may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay E. Gold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 82 | |
| 2 | 1990 | 42 | |
| 3 | 1992 | 42 | |
| 4 | 1990 | 36 | |
| 5 | 1991 | 32 | |
| 6 | 1993 | 29 | |
| 7 | 1987 | 21 | |
| 8 | 1988 | 19 | |
| 9 | 1995 | 15 | |
| 10 | 1993 | 15 | |
| 11 | 1989 | 13 | |
| 12 | 1989 | 12 | |
| 13 | 1995 | 12 | |
| 14 | 1995 | 10 | |
| 15 | 1991 | 9 | |
| 16 | 1992 | 8 | |
| 17 | Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma. | 1978 | 8 |
| 18 | 1994 | 4 | |
| 19 | 1995 | 4 | |
| 20 | 1995 | 3 |
About Jay E. Gold
Jay E. Gold is a scholar working on Oncology, Immunology, Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 418 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Viral-associated cancers and disorders (6 papers), Immune Cell Function and Interaction (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Immunotherapy and Immune Responses (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (235 citations), Pathology and Forensic Medicine (151 citations), Genetics (60 citations), Hematology (50 citations) and Neurology (67 citations). Jay E. Gold has collaborated with scholars based in United States. Frequent co-authors include Ralph Zalusky, Amjad Khan, Michael E. Osband, H. J. Ree, S. Malamud, Antonio Castella, James A. Strauchen, V. S. Ghali, James P. Crowley and John M. Cosgrove. Their work appears in journals such as Cancer, American Journal of Hematology, Journal of Surgical Oncology, European Journal of Cancer and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.